Pharmaceuticals

Natural Capital Protocol: Case Study for Novartis

22nd June 2017
Published under: Case Studies,Featured,Protocol Case Studies

The company in brief: Novartis is a multinational pharmaceutical company based in Switzerland, and one of the largest pharmaceutical companies by both market cap and sales. Novartis develops, manufactures, and markets healthcare products, providing solutions for patients worldwide. The company operates in the segments of innovative pharmaceuticals, eyecare, generics, vaccines/diagnostics and consumer health. Why a… [more]

Commonwealth Urges Policy Reform on Coasts, Oceans

12th October 2016
Published under: Enabling Environment,Why Natural Capital?

This article was originally published on: Jamaica Observer. New research by the Commonwealth Secretariat has revealed the need for “fundamental changes” to the way the world’s oceans, seas and coastal areas are managed. “…The five-part volume titled Commonwealth Blue Economy Series, recommends that countries embrace new marine-based sectors such as aquaculture, biotechnology and ocean-based renewable energy, while… [more]